Press releases appear below, filter by date.
Gedeon Richter (UK) Ltd has breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.
Shire Pharmaceuticals Ltd and Roche Products Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.
The amended text is available on the PMCPA website
Chiesi Ltd and Vifor Pharma UK Limited have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry. In addition, Chiesi was publicly reprimanded.
Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry were agreed at an Extraordinary General Meeting of the ABPI on Monday 11 June.
Bayer HealthCare has breached Clause 2 of the ABPI Code of Practice and is the subject of advertisements in the medical, pharmaceutical and nursing press.
Merz Pharma, Lilly and Daiichi-Sankyo have each breached the ABPI Code of Practice for the Pharmaceutical Industry and brought discredit upon, and reduced confidence in, the pharmaceutical industry.
Published updates reflect the Second 2012 Edition of the Code.Following recent changes to the ABPI Code of Practice for the Pharmaceutical Industry, the PMCPA has updated its popular e-learning module and quick guides to the Code.
Grünenthal Ltd and Vifor Pharma UK Limited have each breached Clause 2 of the ABPI Code of Practice and are the subject of advertisements in the medical, pharmaceutical and nursing press. In addition, Grünenthal has been publicly reprimanded.
Proposals to amend the ABPI Code of Practice for the Pharmaceutical Industry have been sent to companies and published on the PMCPA website.